Transpercutaneous closure of perimembranous ventricular septal defects by patent ductus occlusion (pdoi)
Main Article Content
Abstract
Background: Ventricular septal defect (VSD) is the most frequently occurring congenital cardiac disease, accounts nearly 20-30% of all cases.
Surgery still the corrective therapy with high success and low complication but having some problems: cardiopulmonary bypass, anesthesia, ICU, sternalitis, chest scar...
Recently many progress in cardiac intervention applied to treat congenital heart disease especially transpercutaneous VSD closure. currently patients with VSD have other choice to cure safely, effectively and less complication.[1]
Objectives: To evaluate the long-term rusults from transpercutaneous closure of perimembranous VSD by PDOI.
Methods: This is the descriptive clinical trial and follow-up.
Result: 112 patients selected by echocardiography, 107 patients were closed successfully (95.5% success rate), mean time 41 months (37-60) follow-up: occlusive rate 99.1%, no significant complication (no late AVB, worsened TV regurgitation, aortic valve).
Conclusions: Transpercutaneous closure of perimembranous VSD by PDOI is effective and safe, is suitable for selected PMVSD.
Article Details
Keywords
Perimembranous ventricular septal defects, transpercutaneous closure, PDOI
References
2. Fu, Y.C., et al., Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol, 2006. 47(2): p. 319-25.
3. Trong-Phi, L., F. Rainer-Koz-lik, and S. Horst, Potential complications of Transcatheter closure of ventricular septal defects using PFM NitOclud VSD coils, in Complications during percutaneous intervention for congenital and structural heart disease. 2009, Informa healthcare p. 171-174.
4. Wang, L., et al., Transcatheter closure of congenital perimembranous ventricular septal defect in children using symmetric occluders: an 8-year multiinstitutional experience. Ann Thorac Surg, 2012. 94(2): p. 592-8.
5. Li, P., et al., Arrhythmias after transcatheter closure of perimembranous ventricular septal defects with a modified double-disk occluder: early and long-term results. Heart Vessels, 2012. 27(4): p. 405-10.
6. Predescu, D., et al., Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg, 2008. 136(5): p. 1223-8.
7. Qin, Y., et al., Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder. Am J Cardiol, 2008. 101(12): p. 1781-6.
8. Liu, J., et al., Outcome of transcatheter closure of perimembranous ventricular septal defect with modified double-disk occluder device. Zhonghua Xin Xue Guan Bing Za Zhi, 2010. 38(4): p. 321-5.
9. Trong-Phi, L., Closure of VSDs - PFM coil, in Percutaneous Interventions for Congenital Heart Disease. 2007, Informa healthcare. p. 357-62.
10. Hiếu, N.L., Đánh giá rối loạn nhịp tim (RLNT) trung hạn sau bít thông liên thất (TLT) bằng dụng cụ qua da ở bệnh nhân thông liên thất trên 6 tuổi. tạp chí tim mạch học việt nam, 2013. 64: p. 34-39.
11. Houeijeh, A., et al., Transcatheter closure of a perimembranous ventricular septal defect with Nit-Occlud Le VSD Coil: A French multicentre study. Arch Cardiovasc Dis, 2020. 113(2): p. 104-112.
12. Mohammed, M.H.A., et al., Outcome of ventricular septal defect closure with the Nit-Occlud((R)) Le VSD-Coil: single centre experience. Sudan J Paediatr, 2022. 22(2): p. 172-178.
13. Nguyen, H.L., et al., Nit-Occlud Le VSD coil versus Duct Occluders for percutaneous perimembranous ventricular septal defect closure. Congenit Heart Dis, 2018. 13(4): p. 584-593.
14. Shyu, T.C., et al., Initial experience of transcatheter closure of subarterial VSD with the Amplatzer duct occluder. J Chin Med Assoc, 2017. 80(8): p. 487-491.
15. Bergmann, M., et al., Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients. Pediatr Cardiol, 2021. 42(1): p. 78-88.